News: Emergent BioSolutions Inc (EBS.N)
EBS.N on New York Stock Exchange
17.85USD
2 Aug 2013
17.85USD
2 Aug 2013
Price Change (% chg)
$-0.04 (-0.22%)
$-0.04 (-0.22%)
Prev Close
$17.89
$17.89
Open
$17.87
$17.87
Day's High
$17.87
$17.87
Day's Low
$17.79
$17.79
Volume
2,108
2,108
Avg. Vol
49,557
49,557
52-wk High
$18.25
$18.25
52-wk Low
$12.50
$12.50
Select another date:
Fri, Apr 5 2013
RPT-BRIEF-Emergent Biosolutions to expand clinical trial of TRU-016 and rituximab
April 5 - April 5 - Emergent Biosolutions Inc : * To expand front line CLL clinical trial of TRU-016 and rituximab based on strong patient enrollment and encouraging early clinical data * Source text for Eikon * Further company coverage
Select another date:
- Emergent's CEO Hosts the 2013 Annual Meeting of Stockholders Conference (Transcript)
- Emergent BioSolutions' Management Presents at Bank of America Merrill Lynch 2013 Health Care Conference (Transcript)
- Biodefense: Live By Government Contracts, Die By Government Contracts
- Emergent Biosolutions Management Presents at Cowen Health Care Conference (Transcript)
- Emergent BioSolutions' CEO Discusses Q1 2013 Results - Earnings Call Transcript
- Emergent Biosolutions CEO Discusses Acquisition of HPPD (Transcript)
Press Releases
- Emergent BioSolutions Closes on Its Acquisition of Healthcare Protective Products Division from Bracco Diagnostics Inc.
- Emergent BioSolutions to Webcast Presentation at Wedbush 2013 Life Sciences Management Access Conference
- General George A. Joulwan Joins Emergent BioSolutions Board of Directors
- Emergent BioSolutions Advances Program Supporting Licensure of a Post-Exposure Prophylaxis Indication for BioThrax
- Emergent BioSolutions to Release Second Quarter 2013 Financial Results and Conduct a Conference Call on August 5, 2013
- Emergent BioSolutions Receives Paul-Ehrlich-Institut Approval to Market BioThrax in Germany
- Mayor Virg Bernero Leads Ribbon Cutting of Emergent BioSolutions’ New Administration Building Representing Another Step in Its Lansing Campus Expansion
- Emergent BioSolutions EVP Corporate Affairs Allen Shofe Appointed to MdBio Foundation Board of Directors
- Emergent BioSolutions to Participate in June and July 2013 Investor Conferences
- Emergent BioSolutions to Webcast Presentation at Jefferies 2013 Global Healthcare Conference

